IGC Pharma (IGC) EBT Margin (2010 - 2025)
IGC Pharma (IGC) reported EBT Margin of 953.4% for Q3 2025, down 53666.0% year-over-year from N/an in Q3 2024, and down 95.57% quarter-over-quarter from 487.5% in Q2 2025.
IGC Pharma (IGC) EBT Margin (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has 16 years of EBT Margin data on file, last reported at 953.4% in Q3 2025.
- EBT Margin for Q3 2025 came in at 953.4%, down 53666.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 582.91% (up 47956.0% YoY), and the FY2026 annual result was 757.73%, down 19746.0% from the prior year.
- EBT Margin retreated to 953.4% in Q3 2025 per IGC's latest filing, from 487.5% in the prior quarter.
- Over five years, EBT Margin peaked at 363.03% in Q1 2025 and troughed at 7757.14% in Q3 2021.
- A 5-year average of 1847.12% and a median of 977.97% in 2024 frame the typical range for EBT Margin.
- On a YoY basis, EBT Margin climbed as much as 723512 bps in 2021 and fell as far as 643154 bps in 2021.
- A 5-year view of EBT Margin shows it stood at 1676.76% in 2021, then surged by 60 bps to 677.41% in 2022, then slumped by 304 bps to 2739.71% in 2023, then soared by 74 bps to 711.67% in 2024, then plunged by 34 bps to 953.4% in 2025.
- Business Quant data shows IGC's EBT Margin at 953.4% in Q3 2025, 487.5% in Q2 2025, and 363.03% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 6.40% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -953.40% |
| Jun 30, 2025 | -487.50% |
| Mar 31, 2025 | -363.03% |
| Dec 31, 2024 | -711.67% |
| Sep 30, 2024 | -416.75% |
| Jun 30, 2024 | -874.26% |
| Mar 31, 2024 | -977.97% |
| Dec 31, 2023 | -2,739.71% |
| Sep 30, 2023 | -842.27% |
| Jun 30, 2023 | -373.87% |
| Mar 31, 2023 | -2,427.71% |
| Dec 31, 2022 | -677.41% |
| Sep 30, 2022 | -1,208.91% |
| Jun 30, 2022 | -1,313.68% |
| Mar 31, 2022 | -5,330.33% |
| Dec 31, 2021 | -1,676.76% |
| Sep 30, 2021 | -7,757.14% |
| Jun 30, 2021 | -2,322.08% |
| Mar 31, 2021 | -3,640.74% |
| Dec 31, 2020 | -2,150.93% |